Pfizer COVID vaccines safe and effective for small children, FDA says

U.S. Food and Drug Administration staff reviewers on Sunday said Pfizer-BioNTech's COVID-19 vaccines were effective and safe for use in children aged 6 months to 4 years...

Valneva functioning on remediation plan for COVID-19 vaccine candidate

French drugmaker Valneva said on Friday it had proposed a remediation plan after receiving the European Commission's notice of intent to terminate the advance purchase agreement for its inactivated COVID-19 vaccine candidate...

Cargo-Partner releases its plan to expand in India

Global logistics service provider cargo-partner has announced its plan to expand to 10 more Indian cities in the next two-three years. After this expansion, cargo-partner will be present in over 24 cities and all major states of India.

Dr Reddy's arm inks pact with US-based Olema Pharmaceuticals

Reddy's Laboratories on Thursday said its subsidiary has inked a pact with US-based Olema Pharmaceuticals Inc to research, develop and commercialise novel small molecule inhibitors of an undisclosed oncology target. Olema and Aurigene Discovery...

SII seeks from DCGI market authorization for India's first qHPV vaccine against cervical cancer

Serum Institute of India (SII) has applied to the country's drug regulator seeking market authorisation to manufacture indigenously developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer, official sources...

Emergency Use of Novavax COVID-19 Vaccine for citizens Aged 18 Years and Older Authorized

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products...

Boehringer Ingelheim obtains ad-interim injunctions against four domestic pharmaceutical companies

German drugmaker Boehringer Ingelheim has obtained ad-interim injunctions against four domestic pharmaceutical companies that launched generic versions of Boehringer Ingelheim’s patent-protected drug Linagliptin, which is marketed under the brand...

Pfizer to spend $120 mln to increase U.S. COVID pill manufacturing

Pfizer Inc said on Monday it would spend $120 million to boost manufacturing of ...

Zydus Lifesciences receives USFDA approval for Famotidine tablets

Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Famotidine tablets in 20 mg and 40 mg strengths (USRLD: Pepcid)...

P&G Health collaborates with Lakshya and Recycle India Foundation to promote sustainable pharmacy waste segregation and management

This World Environment Day, P&G Health reinforced its commitment to sustainable waste management through its new partnership with the Lakshya and Recycle India Foundation for sustainable pharmacy waste segregation and management project as part...

© 2025 India Pharma Outlook. All Rights Reserved.